Ivan K. Blumenthal is a corporate and securities attorney at Mintz. Ivan guides deals and capital markets transactions work for underwriters, companies, and investors. He represents parties in critical business transactions, including initial and follow-on public offerings, and PIPE transactions.
Partner and National Director of SEC Services, CohnReznick
Managing Director, Health Care Investment Banking, Raymond James
David P. Luci
President & CEO, Dipexium Pharamceuticals, Inc.
VP and CFO, Adma Biologics, Inc.